Home Featured Page 269

Featured

Latest

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and Psychiatry’s, Wild Ride

High Hopes in the Mile High City: Inside Colorado’s First Licensed Psilocybin Center

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

Oakland Psychedelic Conference

Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry...

Bright Minds Biosciences Inc. Announces Pricing of Public Marketed Offering of...

Researchers to Investigate Whether DMT Can Accelerate Recovery from Stroke

Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets...

PT232 – Dr. Ryan Westrum – Who We Are Without Medicine

PharmaTher Announces Research Collaboration with Terasaki Institute for Novel Microneedle Delivery...

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Bright Minds Biosciences Inc. Announces Marketed Public Offering

Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

1...268269270...285 Page 269 of 285

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and...

High Hopes in the Mile High City: Inside Colorado’s First Licensed...

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and Psychiatry’s, Wild Ride

High Hopes in the Mile High City: Inside Colorado’s First Licensed Psilocybin Center

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

Psychedelic Science 2025

Oakland Psychedelic Conference

Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry...

Bright Minds Biosciences Inc. Announces Pricing of Public Marketed Offering of...

Researchers to Investigate Whether DMT Can Accelerate Recovery from Stroke

DMT Pricing Guide

Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets...

PT232 – Dr. Ryan Westrum – Who We Are Without Medicine

PharmaTher Announces Research Collaboration with Terasaki Institute for Novel Microneedle Delivery...

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Bright Minds Biosciences Inc. Announces Marketed Public Offering

Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

EDITOR PICKS

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and...

High Hopes in the Mile High City: Inside Colorado’s First Licensed...

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY